Giulia Maria De Benedictis

Prof. Dr. Giulia Maria De Benedictis

Dep Animal Medicine, Productions and Health, University of Padova, Italy
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CGChiara Gardin
Chiara Gardin
SRSara Ricci
Sara Ricci
LFLetizia Ferroni
Letizia Ferroni
Riccardo GuazzoRiccardo Guazzo
Riccardo Guazzo
Luca SbricoliLuca Sbricoli
Luca Sbricoli
Barbara ZavanBarbara Zavan
Barbara Zavan
The combination of bone grafting materials with guided bone regeneration (GBR) membranes seems to provide promising results to restore bone defects in dental clinical practice. In the first part of this work, a novel protocol for decellularization and delipidation of bovine bone, based on multiple steps of thermal shock, washes with detergent and dehydration with alcohol, is described. This protocol is more effective in removal of cellular materials, and shows superior biocompatibility compared to other three methods tested in this study. Furthermore, histological and morphological analyses confirm the maintenance of an intact bone extracellular matrix (ECM). In vitro and in vivo experiments evidence osteoinductive and osteoconductive properties of the produced scaffold, respectively. In the second part of this study, two methods of bovine pericardium decellularization are compared. The osmotic shock-based protocol gives better results in terms of removal of cell components, biocompatibility, maintenance of native ECM structure, and host tissue reaction, in respect to the freeze/thaw method. Overall, the results of this study demonstrate the characterization of a novel protocol for the decellularization of bovine bone to be used as bone graft, and the acquisition of a method to produce a pericardium membrane suitable for GBR applications.

14 August 2012 in Journal of Orthopaedic Research
Verified
Journal Article
Open access
PDF file
TMTiziana Martinello
Tiziana Martinello
IBIlaria Bronzini
Ilaria Bronzini
APAnna Perazzi
Anna Perazzi
STStefania Testoni
Stefania Testoni
GBGiulia Maria De Benedictis
Giulia Maria De Benedictis
MPMarco Patruno
Marco Patruno
Tendon injuries, degenerative tendinopathies, and overuse tendinitis are common in races horses. Novel therapies aim to restore tendon functionality by means of cell‐based therapy, growth factor delivery, and tissue engineering approaches. This study examined the use of autologous mesenchymal stromal cells derived from peripheral blood (PB‐MSCs), platelet‐rich plasma (PRP) and a combination of both for ameliorating experimental lesions on deep digital flexor tendons (DDFT) of Bergamasca sheep. In particular, testing the combination of blood‐derived MSCs and PRP in an experimental animal model represents one of the few studies exploring a putative synergistic action of these treatments. Effectiveness of treatments was evaluated at 30 and 120 days comparing clinical, ultrasonographic, and histological features together with immunohistochemical expression of collagen types 1 and 3, and cartilage oligomeric matrix protein (COMP). Significant differences were found between treated groups and their corresponding controls (placebo) regarding tendon morphology and extracellular matrix (ECM) composition. However, our results indicate that the combined use of PRP and MSCs did not produce an additive or synergistic regenerative response and highlighted the predominant effect of MSCs on tendon healing, enhanced tissue remodeling and improved structural organization. © 2012 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 31: 306–314, 2013

25 June 2018 in BMC Veterinary Research
Verified
Journal Article
Open access
PDF file
TMT. Martinello
T. Martinello
CGChiara Gomiero
Chiara Gomiero
APAnna Perazzi
Anna Perazzi
IIIlaria Iacopetti
Ilaria Iacopetti
FGF. Gemignani
F. Gemignani
MPMarco Patruno
Marco Patruno
Skin wound healing includes a system of biological processes, collectively restoring the integrity of the skin after injury. Healing by second intention refers to repair of large and deep wounds where the tissue edges cannot be approximated and substantial scarring is often observed. The objective of this study was to evaluate the effects of mesenchymal stem cells (MSCs) in second intention healing using a surgical wound model in sheep. MSCs are known to contribute to the inflammatory, proliferative, and remodeling phases of the skin regeneration process in rodent models, but data are lacking for large animal models. This study used three different approaches (clinical, histopathological, and molecular analysis) to assess the putative action of allogeneic MSCs at 15 and 42 days after lesion creation. At 15 days post-lesion, the wounds treated with MSCs showed a higher degree of wound closure, a higher percentage of re-epithelialization, proliferation, neovascularization and increased contraction in comparison to a control group. At 42 days, the wounds treated with MSCs had more mature and denser cutaneous adnexa compared to the control group. The MSCs-treated group showed an absence of inflammation and expression of CD3+ and CD20+. Moreover, the mRNA expression of hair-keratine (hKER) was observed in the MSCs-treated group 15 days after wound creation and had increased significantly by 42 days post-wound creation. Collagen1 gene (Col1α1) expression was also greater in the MSCs-treated group compared to the control group at both days 15 and 42. Peripheral blood-derived MSCs may improve the quality of wound healing both for superficial injuries and deep lesions. MSCs did not induce an inflammatory response and accelerated the appearance of granulation tissue, neovascularization, structural proteins, and skin adnexa.

1 April 2004 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
NBNicola Baldan
Nicola Baldan
PRPaolo Rigotti
Paolo Rigotti
FCFiorella Calabrese
Fiorella Calabrese
RCRoberto Cadrobbi
Roberto Cadrobbi
ADArben Dedja
Arben Dedja
EAErmanno Ancona
Ermanno Ancona
The aim of this study was to analyze the incidence of ureteral stenosis in a life-supporting human decay-accelerating factor (hDAF) transgenic pig-to-cynomolgus monkey kidney transplantation model and determine the role of possible immunological events in its pathogenesis. Thirty consecutive bi-nephrectomized cynomolgus monkeys received a kidney from hDAF transgenic pigs with or without a ureteral stent. Four monkeys were euthanized prematurely after transplantation. In the remaining 26 cases, the mean survival was 24 +/- 19 days. Except in one case, there was a close relationship between ureter and kidney in terms of type and severity of rejection. There were six ureteral stenoses; five were repaired by stent positioning and resurgery extended survival for an additional 16 +/- 10 days. The stenotic ureters showed diffuse acute humoral xenograft rejection (AHXR), while all cases with no or only focal signs of ureteral rejection never revealed ureteral obstruction. Use of a ureteral stent extends the survival of a xenografted primate, thereby helping to clarify the immunological events surrounding the onset of AHXR in kidneys in long-term xenograft recipients.

24 March 2016 in Experimental Physiology
Verified
Journal Article
Closed access
PDF file
ANArturo Nicola Natali
Arturo Nicola Natali
E. L. CarnielE. L. Carniel
E. L. Carniel
AFAlessandro Frigo
Alessandro Frigo
PPPiero Giovanni Pavan
Piero Giovanni Pavan
Silvia TodrosSilvia Todros
Silvia Todros
GBGiulia Maria De Benedictis
Giulia Maria De Benedictis

19 February 2019 in Annals of Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
Chiara Giulia FontanellaChiara Giulia Fontanella
Chiara Giulia Fontanella
CSClaudia Salmaso
Claudia Salmaso
ITIlaria Toniolo
Ilaria Toniolo
NCNiccolò de Cesare
Niccolò de Cesare
ARAlessandro Rubini
Alessandro Rubini
E. L. CarnielE. L. Carniel
E. L. Carniel